Severe consequences of carbamazepine exposure in utero

about

Severe consequences of carbamazepine exposure in utero

Item

http://www.wikidata.org/entity/Q35983179

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Severe consequences of carbamazepine exposure in utero

@ast

Severe consequences of carbamazepine exposure in utero

@en

type

Item

label

Severe consequences of carbamazepine exposure in utero

@ast

Severe consequences of carbamazepine exposure in utero

@en

prefLabel

Severe consequences of carbamazepine exposure in utero

@ast

Severe consequences of carbamazepine exposure in utero

@en

P1476

Severe consequences of carbamazepine exposure in utero

@en

P2093

Antonio Bravo

http://www.w3.org/2001/XMLSchema#string

Carmen Esmer

http://www.w3.org/2001/XMLSchema#string

Dolores Hernandez

http://www.w3.org/2001/XMLSchema#string

Gabriela Elizondo

http://www.w3.org/2001/XMLSchema#string

Laura Martinez-Villarreal

http://www.w3.org/2001/XMLSchema#string

P2860

Is carbamazepine teratogenic? A prospective controlled study of 210 pregnancies.

Idiosyncratic drug-induced agranulocytosis or acute neutropenia.

Dysmorphic features: an important clue to the diagnosis and severity of fetal anticonvulsant syndromes.

Vitamin K--its essential role in craniofacial development. A review of the literature regarding vitamin K and craniofacial development.

Fetal anticonvulsant syndromes and polymorphisms in MTHFR, MTR, and MTRR.

P31

scholarly article

case report

P356

10.1136/BCR.05.2011.4243

http://www.w3.org/2001/XMLSchema#string

P478

2011

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22687674

http://www.w3.org/2001/XMLSchema#string

P932

4545117

http://www.w3.org/2001/XMLSchema#string